Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Rizzo

Showing results (111-120 of 381) with videos related to

Pageof 39
Sort By:
Expert Opinion on Investigational Drugs|February 16, 2022
Ladiratuzumab vedotin for metastatic triple negative cancer: preliminary results, key challenges, and clinical potentialAlessandro Rizzo, Antonio Cusmai, Silvana Acquafredda, et al.
IEEE Access : Practical Innovations, Open Solutions|January 3, 2022
Design and Feasibility Study of the Mobile Application StopTheSpreadMatthieu Nadini, Samuel Richmond, Jiayi Huang, et al.
Cancer Treatment Reviews|March 23, 2025
Post-progression treatment options after CDK4/6 inhibitors in hormone receptor-positive, HER2-negative metastatic breast cancerTaha Koray Sahin, Alessandro Rizzo, Deniz Can Guven, et al.
Immunotherapy|April 7, 2021
Determinants of treatment for first-line immune-based combinations in metastatic renal cell carcinoma: a critical overview of recent evidenceAlessandro Rizzo, Matteo Rosellini, Andrea Marchetti, et al.
Expert Review of Gastroenterology & Hepatology|August 25, 2021
First-line immune checkpoint inhibitor-based combinations in unresectable hepatocellular carcinoma: current management and future challengesAlessandro Rizzo, Angela Dalia Ricci, Gennaro Gadaleta-Caldarola, et al.
Physical Review Letters|March 21, 2008
Synchronization of moving chaotic agentsMattia Frasca, Arturo Buscarino, Alessandro Rizzo, et al.
Thoracic Cancer|March 4, 2023
Safety evaluation of immune checkpoint inhibitors combined with chemotherapy for the treatment of small cell lung cancer: A meta-analysis of randomized controlled trialsVito Longo, Alessandro Rizzo, Annamaria Catino, et al.
Cancers|November 9, 2024
Prognostic Value of Neutrophil-to-Eosinophil Ratio (NER) in Cancer: A Systematic Review and Meta-AnalysisTaha Koray Sahin, Ruveyda Ayasun, Alessandro Rizzo, et al.
Biology|February 12, 2026
Association Between Systemic Immune-Inflammatory Index (SII) and Cancer Grading and Staging: Evidence from the Current Scientific LiteratureAlessandro Rizzo, Elsa Vitale, Lorenza Maistrello, et al.
Scientific Reports|December 20, 2022
Game theoretical trajectory planning enhances social acceptability of robots by humansGiada Galati, Stefano Primatesta, Sergio Grammatico, et al.
Pageof 39

Showing results (111-120 of 381) with videos related to

Sort By:
Pageof 39
Expert Opinion on Investigational Drugs|February 16, 2022
Ladiratuzumab vedotin for metastatic triple negative cancer: preliminary results, key challenges, and clinical potentialAlessandro Rizzo, Antonio Cusmai, Silvana Acquafredda, et al.
IEEE Access : Practical Innovations, Open Solutions|January 3, 2022
Design and Feasibility Study of the Mobile Application StopTheSpreadMatthieu Nadini, Samuel Richmond, Jiayi Huang, et al.
Cancer Treatment Reviews|March 23, 2025
Post-progression treatment options after CDK4/6 inhibitors in hormone receptor-positive, HER2-negative metastatic breast cancerTaha Koray Sahin, Alessandro Rizzo, Deniz Can Guven, et al.
Immunotherapy|April 7, 2021
Determinants of treatment for first-line immune-based combinations in metastatic renal cell carcinoma: a critical overview of recent evidenceAlessandro Rizzo, Matteo Rosellini, Andrea Marchetti, et al.
Expert Review of Gastroenterology & Hepatology|August 25, 2021
First-line immune checkpoint inhibitor-based combinations in unresectable hepatocellular carcinoma: current management and future challengesAlessandro Rizzo, Angela Dalia Ricci, Gennaro Gadaleta-Caldarola, et al.
Physical Review Letters|March 21, 2008
Synchronization of moving chaotic agentsMattia Frasca, Arturo Buscarino, Alessandro Rizzo, et al.
Thoracic Cancer|March 4, 2023
Safety evaluation of immune checkpoint inhibitors combined with chemotherapy for the treatment of small cell lung cancer: A meta-analysis of randomized controlled trialsVito Longo, Alessandro Rizzo, Annamaria Catino, et al.
Cancers|November 9, 2024
Prognostic Value of Neutrophil-to-Eosinophil Ratio (NER) in Cancer: A Systematic Review and Meta-AnalysisTaha Koray Sahin, Ruveyda Ayasun, Alessandro Rizzo, et al.
Biology|February 12, 2026
Association Between Systemic Immune-Inflammatory Index (SII) and Cancer Grading and Staging: Evidence from the Current Scientific LiteratureAlessandro Rizzo, Elsa Vitale, Lorenza Maistrello, et al.
Scientific Reports|December 20, 2022
Game theoretical trajectory planning enhances social acceptability of robots by humansGiada Galati, Stefano Primatesta, Sergio Grammatico, et al.
Pageof 39